Hypertension, Vol 22, 735-742, Copyright © 1993 by American Heart Association
AM Kahn, CL Seidel, JC Allen, RG O'Neil, H Shelat and T Song
Resistance to insulin-induced glucose disposal is associated with
hypertension, in accord with recent reports that insulin-induced
vasodilation is impaired in men with resistance to insulin-induced glucose
disposal. Nevertheless, the mechanism of insulin-induced vasodilation is
not known. We wished to determine whether a physiological concentration of
insulin inhibits agonist-induced contraction at the level of the individual
vascular smooth muscle cell, and if so, how. Dispersed vascular smooth
muscle cells from dog femoral artery were grown on collagen gels for 4 to 8
days. Contraction and intracellular Ca2+ concentration of individual cells
were measured by photomicroscopy and fura 2 epifluorescence microscopy,
respectively. Serotonin and angiotensin II contracted cells in a
dose-dependent manner. Preincubation of cells for 20 minutes (short-term)
or 7 days (long-term) with insulin (40 microU/mL) inhibited serotonin- and
angiotensin II-induced contractions by approximately 50%. Insulin (10
microU/mL) acutely inhibited serotonin-induced contraction by 34%. The
maximal effect of high extracellular K(+)-induced contraction was not
affected by short-term insulin exposure, but the ED50 for extracellular
K(+)-induced contraction was increased from 7.6 +/- 2.5 to 16.0 +/- 3.9
mmol/L (P < .05). Short-term insulin exposure also attenuated the peak
rise of the serotonin-induced intracellular Ca2+ transient and increased
the rate constant for intracellular Ca2+ decline. Verapamil and ouabain
completely blocked the attenuation of agonist-induced contraction by
short-term insulin exposure, indicating the importance of voltage-operated
Ca2+ channels and the Na(+)-K+ pump for this effect.(ABSTRACT TRUNCATED AT
250 WORDS)
ARTICLES
Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle
Department of Medicine, University of Texas Medical School, Houston.
This article has been cited by other articles:
![]() |
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Egecioglu, I. J. Andersson, E. Bollano, V. Palsdottir, B. G. Gabrielsson, J. J. Kopchick, O. Skott, P. Bie, J. Isgaard, M. Bohlooly-Y, et al. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1418 - E1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. J. Lott, C. Hogeman, M. Herr, R. Gabbay, and L. I. Sinoway Effects of an oral glucose tolerance test on the myogenic response in healthy individuals Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H304 - H310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, Y. Yang, S. Zhang, and A. M. Kahn Insulin-Stimulated Hydrogen Peroxide Increases Guanylate Cyclase Activity in Vascular Smooth Muscle Hypertension, October 1, 2003; 42(4): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tao, S. Chaudry, B. Tolloczko, J. G. Martin, and S. M. Kelly Modulation of smooth muscle phenotype in vitro by homologous cell substrate Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1531 - C1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, Y. Yang, B. C. Kone, J. C. Allen, and A. M. Kahn Insulin-Stimulated Cyclic Guanosine Monophosphate Inhibits Vascular Smooth Muscle Cell Migration by Inhibiting Ca/Calmodulin-Dependent Protein Kinase II Circulation, March 25, 2003; 107(11): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Clerk, S. Rattigan, and M. G. Clark Lipid Infusion Impairs Physiologic Insulin-Mediated Capillary Recruitment and Muscle Glucose Uptake In Vivo Diabetes, April 1, 2002; 51(4): 1138 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ceolotto, R. Valente, E. Baritono, S. Reato, E. Iori, A. Monari, R. Trevisan, and A. Semplicini Effect of Insulin and Angiotensin II on Cell Calcium in Human Skin Fibroblasts Hypertension, June 1, 2001; 37(6): 1486 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhao, R. L. Sutliff, C. S. Weber, J. Wang, J. Lorenz, R. J. Paul, and J. A. Fagin Smooth Muscle-Targeted Overexpression of Insulin-Like Growth Factor I Results in Enhanced Vascular Contractility Endocrinology, February 1, 2001; 142(2): 623 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Michea, V. Irribarra, I. A. Goecke, and E. T. Marusic Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H851 - H858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Begum, N. Duddy, O. Sandu, J. Reinzie, and L. Ragolia Regulation of Myosin-Bound Protein Phosphatase by Insulin in Vascular Smooth Muscle Cells: Evaluation of the Role of Rho Kinase and Phosphatidylinositol-3-Kinase-Dependent Signaling Pathways Mol. Endocrinol., September 1, 2000; 14(9): 1365 - 1376. [Abstract] [Full Text] |
||||
![]() |
A. M. Kahn, J. C. Allen, C. L. Seidel, D. S. Lichtenberg, T. Song, and S. Zhang Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vehkavaara, S. Makimattila, A. Schlenzka, J. Vakkilainen, J. Westerbacka, and H. Yki-Jarvinen Insulin Therapy Improves Endothelial Function in Type 2 Diabetes Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nava, V. Guarner, R. Posadas, I. Perez, and G. Banos Insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H399 - H404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Goud, B. Pitt, R. C. Webb, and J. M. Richey Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E882 - E887. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Abdelbaky, G. B. Brock, and H. Huynh Improvement of Erectile Function in Diabetic Rats by Insulin: Possible Role of the Insulin-Like Growth Factor System Endocrinology, July 1, 1998; 139(7): 3143 - 3147. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Sung, M. Ching, J. Izzo Jr, P. Dandona, and M. F. Wilson Insulin-Mediated Venodilation Is Impaired in Patients With High Cholesterol Hypertension, June 1, 1998; 31(6): 1266 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kahn, A. Husid, T. Odebunmi, J. C. Allen, C. L. Seidel, and T. Song Insulin inhibits vascular smooth muscle contraction at a site distal to intracellular Ca2+ concentration Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E885 - E892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Moore, M. A. Maher, W. J. Banz, and M. B. Zemel Chromium Picolinate Modulates Rat Vascular Smooth Muscle Cell Intracellular Calcium Metabolism J. Nutr., February 1, 1998; 128(2): 180 - 184. [Abstract] [Full Text] |
||||
![]() |
U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text] |
||||
![]() |
A. M. Kahn, A. Husid, J. C. Allen, C. L. Seidel, and T. Song Insulin Acutely Inhibits Cultured Vascular Smooth Muscle Cell Contraction by a Nitric Oxide Synthase–Dependent Pathway Hypertension, October 1, 1997; 30(4): 928 - 933. [Abstract] [Full Text] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Angiotensin II Regulates Vascular Smooth Muscle Cell pH, Contraction, and Growth Via Tyrosine Kinase–Dependent Signaling Pathways Hypertension, August 1, 1997; 30(2): 222 - 229. [Abstract] [Full Text] |
||||
![]() |
E. Bouskela, F. Z. G. A. Cyrino, N. Wiernsperger, and E. Bouskela Effects of Insulin and the Combination of Insulin Plus Metformin (Glucophage) on Microvascular Reactivity in Control and Diabetic Hamsters Angiology, June 1, 1997; 48(6): 503 - 514. [Abstract] [PDF] |
||||
![]() |
H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato Calcium Movements, Distribution, and Functions in Smooth Muscle Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text] |
||||
![]() |
C. J.J. Tack, J. A. Lutterman, G. Vervoort, T. Thien, and P. Smits Activation of the Sodium-Potassium Pump Contributes to Insulin-Induced Vasodilation in Humans Hypertension, September 1, 1996; 28(3): 426 - 432. [Abstract] [Full Text] |
||||
![]() |
S.-Z. Han, Y. Ouchi, H. Karaki, and H. Orimo Inhibitory Effects of Insulin on Cytosolic Ca2+ Level and Contraction in the Rat Aorta : Endothelium-Dependent and -Independent Mechanisms Circ. Res., October 1, 1995; 77(4): 673 - 678. [Abstract] [Full Text] |
||||
![]() |
A. M. Kahn, R. A. Lichtenberg, J. C. Allen, C. L. Seidel, and T. Song Insulin-Stimulated Glucose Transport Inhibits Ca2+ Influx and Contraction in Vascular Smooth Muscle Circulation, September 15, 1995; 92(6): 1597 - 1603. [Abstract] [Full Text] |
||||
![]() |
A. Grover, C. Padginton, M. F. Wilson, B. H. Sung, J. L. Izzo Jr, and P. Dandona Insulin Attenuates Norepinephrine- Induced Venoconstriction : An Ultrasonographic Study Hypertension, April 1, 1995; 25(4): 779 - 784. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |